EFFISAYIL Trademark

Trademark Overview

On Wednesday, May 15, 2019, a trademark application was filed for EFFISAYIL with the United States Patent and Trademark Office. The USPTO has given the EFFISAYIL trademark a serial number of 79263555. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Wednesday, February 11, 2026. This trademark is owned by Boehringer Ingelheim International GmbH. The EFFISAYIL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the field of immunology [ , oncology and immuno-oncology ] ; providing medical and scientific research information in the field of immunology [ , oncology and immuno-oncology ]
effisayil

General Information

Serial Number79263555
Word MarkEFFISAYIL
Filing DateWednesday, May 15, 2019
Status706 - SECTION 71 ACCEPTED
Status DateWednesday, February 11, 2026
Registration Number5947032
Registration DateTuesday, December 31, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 15, 2019

Trademark Statements

Goods and ServicesMedical and scientific research in the field of immunology [ , oncology and immuno-oncology ] ; providing medical and scientific research information in the field of immunology [ , oncology and immuno-oncology ]

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 26, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLEO Pharma A/S
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressDK
Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressIngelheim 55218
DE
Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressIngelheim 55218
DE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressIngelheim 55218
DE

Trademark Events

Event DateEvent Description
Thursday, July 25, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, July 26, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 26, 2019ASSIGNED TO EXAMINER
Tuesday, July 30, 2019APPLICATION FILING RECEIPT MAILED
Monday, August 5, 2019NON-FINAL ACTION WRITTEN
Tuesday, August 6, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, August 24, 2019REFUSAL PROCESSED BY MPU
Saturday, August 24, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, September 4, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 4, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 5, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 11, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 12, 2019ASSIGNED TO LIE
Friday, September 13, 2019REFUSAL PROCESSED BY IB
Wednesday, September 25, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 25, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 25, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, October 12, 2019NOTIFICATION PROCESSED BY IB
Tuesday, October 15, 2019PUBLISHED FOR OPPOSITION
Tuesday, October 15, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 31, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, March 31, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, April 16, 2020FINAL DISPOSITION PROCESSED
Thursday, April 16, 2020FINAL DISPOSITION NOTICE SENT TO IB
Friday, May 1, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, December 31, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, October 9, 2025TEAS SECTION 71 RECEIVED
Thursday, December 25, 2025CHANGE OF OWNER RECEIVED FROM IB
Monday, February 9, 2026CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, February 11, 2026REGISTERED-SEC.71 ACCEPTED
Wednesday, February 11, 2026NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

Related Keywords

effisayil oncology immuno medical immunology field scientific research information providing